• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.辅助和转移性乳腺癌患者使用电子调查问卷(ePRO)的意愿取决于社会人口统计学因素、健康相关生活质量、疾病状态和计算机技能。
Geburtshilfe Frauenheilkd. 2016 May;76(5):535-541. doi: 10.1055/s-0042-105872.
2
Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.基于电子设备的患者报告结局:辅助性和转移性乳腺癌患者的意愿、需求及障碍
JMIR Cancer. 2017 Aug 7;3(2):e11. doi: 10.2196/cancer.6996.
3
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.电子患者报告结局应用程序在乳腺癌患者健康相关生活质量中的实施:在一项两中心前瞻性试验中的评估和可接受性分析。
J Med Internet Res. 2022 Feb 8;24(2):e16128. doi: 10.2196/16128.
4
Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study.电子患者报告结局测量工具在老年癌症患者中的可用性:一项观察性单中心研究数据的二次分析。
J Med Internet Res. 2023 Sep 21;25:e49476. doi: 10.2196/49476.
5
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.一种用于测量乳腺癌患者健康相关生活质量的FACT-B(癌症治疗功能评估-乳腺癌)问卷的电子患者报告结局工具:可靠性研究
J Med Internet Res. 2019 Jan 22;21(1):e10004. doi: 10.2196/10004.
6
Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home.对癌症患者在医院和家中进行电子患者报告结局评估。
BMC Med Inform Decis Mak. 2015 Dec 23;15:110. doi: 10.1186/s12911-015-0230-y.
7
[Practicability and Efficiency of E-health Applications in Patient-Reported Outcomes: State of and Need for Research].[电子健康应用在患者报告结局中的实用性与效率:研究现状与需求]
Gesundheitswesen. 2018 Nov;80(11):953-962. doi: 10.1055/s-0044-100037. Epub 2018 Feb 27.
8
Capturing patient-reported outcomes: paper versus electronic survey administration.获取患者报告的结果:纸质调查与电子调查管理方式
OTA Int. 2022 Sep 8;5(3):e212. doi: 10.1097/OI9.0000000000000212. eCollection 2022 Sep.
9
Data Quality of Longitudinally Collected Patient-Reported Outcomes After Thoracic Surgery: Comparison of Paper- and Web-Based Assessments.胸腔手术后纵向收集的患者报告结局数据质量:纸质和网络评估的比较。
J Med Internet Res. 2021 Nov 9;23(11):e28915. doi: 10.2196/28915.
10
Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients' Health Status in Greater Detail?转移性癌症患者在医院进行纸质版与在家持续进行电子患者报告结局的随机对照试验:在家进行电子测量能否更详细地检测患者的健康状况?
Med Decis Making. 2022 Jan;42(1):60-67. doi: 10.1177/0272989X211010171. Epub 2021 Apr 24.

引用本文的文献

1
Electronic patient-reported outcome systems and capabilities in cancer care: a systematic review.癌症护理中的电子患者报告结局系统及功能:一项系统综述
Front Digit Health. 2025 Aug 18;7:1560533. doi: 10.3389/fdgth.2025.1560533. eCollection 2025.
2
Advancing patient-centered cancer care: a systematic review of electronic patient-reported outcome measures.推进以患者为中心的癌症护理:电子患者报告结局指标的系统评价
Front Rehabil Sci. 2024 Sep 25;5:1427712. doi: 10.3389/fresc.2024.1427712. eCollection 2024.
3
The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: A systematic review.癌症电子患者报告结局系统的优势、劣势、威胁与机遇:一项系统综述。
Digit Health. 2024 May 27;10:20552076241257146. doi: 10.1177/20552076241257146. eCollection 2024 Jan-Dec.
4
Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.真实世界患者依从性的纵向评估:12 个月电子患者报告结局随访早期乳腺癌治疗女性患者的依从性。
Support Care Cancer. 2024 May 14;32(6):344. doi: 10.1007/s00520-024-08547-7.
5
Health status based on EQ-5D-5L for the cancer patient population in Malaysia.马来西亚癌症患者人群的 EQ-5D-5L 健康状况。
Sci Rep. 2024 Apr 8;14(1):8152. doi: 10.1038/s41598-024-58844-8.
6
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1).以患者为中心的教育(ePRO-E),提高联盟临床试验(A221805-SI1)中的 ePRO 意愿。
JNCI Cancer Spectr. 2024 Jan 4;8(1). doi: 10.1093/jncics/pkae002.
7
Assessments of a novel digital follow-up tool Rehabkompassen to identify rehabilitation needs among stroke patients in an outpatient setting.评估一种新型数字随访工具Rehabkompassen,以识别门诊环境中中风患者的康复需求。
Digit Health. 2022 Jun 3;8:20552076221104662. doi: 10.1177/20552076221104662. eCollection 2022 Jan-Dec.
8
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.电子患者报告结局应用程序在乳腺癌患者健康相关生活质量中的实施:在一项两中心前瞻性试验中的评估和可接受性分析。
J Med Internet Res. 2022 Feb 8;24(2):e16128. doi: 10.2196/16128.
9
Improving Electronic Survey Response Rates Among Cancer Center Patients During the COVID-19 Pandemic: Mixed Methods Pilot Study.在新冠疫情期间提高癌症中心患者的电子调查回复率:混合方法试点研究
JMIR Cancer. 2021 Aug 6;7(3):e30265. doi: 10.2196/30265.
10
Supporting Medical Staff from Psycho-Oncology with Smart Mobile Devices: Insights into the Development Process and First Results.用智能移动设备为心理肿瘤学医护人员提供支持:开发过程及初步成果的相关见解。
Int J Environ Res Public Health. 2021 May 11;18(10):5092. doi: 10.3390/ijerph18105092.

本文引用的文献

1
[Why Strive after Clinical Social Medicine? From Epidemiological Association to Personalized Social Medicine: a Case of Breast Cancer Care].[为何追求临床社会医学?从流行病学关联到个性化社会医学:以乳腺癌护理为例]
Gesundheitswesen. 2016 Feb;78(2):97-102. doi: 10.1055/s-0042-100822. Epub 2016 Feb 23.
2
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.早期乳腺癌绝经前女性接受卵巢抑制时,辅助依西美坦与他莫昔芬的患者报告结局(TEXT和SOFT):两项3期随机试验的联合分析
Lancet Oncol. 2015 Jul;16(7):848-58. doi: 10.1016/S1470-2045(15)00049-2. Epub 2015 Jun 16.
3
Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.乳腺癌骨转移患者的生存情况:一项基于丹麦人群的队列研究,探讨乳腺癌诊断时疾病初始阶段及无骨转移间期长度的预后影响。
BMJ Open. 2015 Apr 29;5(4):e007702. doi: 10.1136/bmjopen-2015-007702.
4
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network.转移性乳腺癌患者的生物标志物与PRAEGNANT研究网络
Geburtshilfe Frauenheilkd. 2015 Jan;75(1):41-50. doi: 10.1055/s-0034-1396215.
5
Tablet, web-based, or paper questionnaires for measuring anxiety in patients suspected of breast cancer: patients' preferences and quality of collected data.用于测量疑似乳腺癌患者焦虑程度的平板、网络或纸质问卷:患者偏好及所收集数据的质量
J Med Internet Res. 2014 Oct 31;16(10):e239. doi: 10.2196/jmir.3578.
6
Prognostic factors for patients with bone-only metastasis in breast cancer.乳腺癌单纯骨转移患者的预后因素。
Yonsei Med J. 2013 Sep;54(5):1168-77. doi: 10.3349/ymj.2013.54.5.1168.
7
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.帕妥珠单抗、曲妥珠单抗和多西他赛联合用于人表皮生长因子受体 2 阳性转移性乳腺癌(CLEOPATRA 研究):一项随机、双盲、安慰剂对照、3 期研究的总生存结果。
Lancet Oncol. 2013 May;14(6):461-71. doi: 10.1016/S1470-2045(13)70130-X. Epub 2013 Apr 18.
8
[Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study].[乳腺癌患者电子心理肿瘤学筛查的接受度与可靠性:一项随机对照研究]
Psychother Psychosom Med Psychol. 2013 Sep;63(9-10):374-80. doi: 10.1055/s-0032-1333301. Epub 2013 Feb 18.
9
Combination anastrozole and fulvestrant in metastatic breast cancer.阿那曲唑与氟维司群联合治疗转移性乳腺癌。
N Engl J Med. 2012 Aug 2;367(5):435-44. doi: 10.1056/NEJMoa1201622.
10
[The benefits of using patient-reported outcomes in cancer treatment: an overview].[使用患者报告结局进行癌症治疗的益处:概述]
Wien Klin Wochenschr. 2012 May;124(9-10):293-303. doi: 10.1007/s00508-012-0168-3. Epub 2012 Apr 27.

辅助和转移性乳腺癌患者使用电子调查问卷(ePRO)的意愿取决于社会人口统计学因素、健康相关生活质量、疾病状态和计算机技能。

Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

作者信息

Graf J, Simoes E, Wißlicen K, Rava L, Walter C B, Hartkopf A, Keilmann L, Taran A, Wallwiener S, Fasching P, Brucker S Y, Wallwiener M

机构信息

Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen; Forschungsinstitut für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen; Abteilung Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Tübingen, Tübingen.

Department für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen; Forschungsinstitut für Frauengesundheit, Universitätsklinikum Tübingen, Tübingen; Stabsstelle Sozialmedizin, Universitätsklinikum Tübingen, Tübingen.

出版信息

Geburtshilfe Frauenheilkd. 2016 May;76(5):535-541. doi: 10.1055/s-0042-105872.

DOI:10.1055/s-0042-105872
PMID:27239062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4873300/
Abstract

Because of the often unfavorable prognosis, particularly for patients with metastases, health-related quality of life is extremely important for breast cancer patients. In recent years, data on patient-relevant endpoints is being increasingly collected electronically; however, knowledge on the acceptance and practicability of, and barriers to, this form of data collection remains limited. A questionnaire was completed by 96 patients to determine to what extent existing computer skills, disease status, health-related quality of life and sociodemographic factors affect patients' potential willingness to use electronics methods of data collection (ePRO). 52 of 96 (55 %) patients reported a priori that they could envisage using ePRO. Patients who a priori preferred a paper-based survey (pPRO) tended to be older (ePRO 53 years vs. pPRO 62 years; p = 0.0014) and typically had lower levels of education (p = 0.0002), were in poorer health (p = 0.0327) and had fewer computer skills (p = 0.0003). Barriers to the prospective use of ePRO were identified in older patients and patients with a lower quality of life. Given the appropriate conditions with regard to age, education and current health status, opportunities to participate should be provided to encourage patients' willingness to take part and ensure the validity of survey results. Focusing on ease of use of ePRO applications and making applications more patient-oriented and straightforward appears to be the way forward.

摘要

由于预后往往不佳,尤其是对于有转移的患者,与健康相关的生活质量对乳腺癌患者极为重要。近年来,与患者相关的终点数据越来越多地通过电子方式收集;然而,关于这种数据收集形式的接受度、实用性以及障碍的知识仍然有限。96名患者完成了一份问卷,以确定现有的计算机技能、疾病状态、与健康相关的生活质量和社会人口学因素在多大程度上影响患者使用电子数据收集方法(电子患者报告结局,ePRO)的潜在意愿。96名患者中有52名(55%)事先表示他们可以设想使用ePRO。事先更喜欢纸质调查问卷(pPRO)的患者往往年龄较大(ePRO组53岁,pPRO组62岁;p = 0.0014),教育水平通常较低(p = 0.0002),健康状况较差(p = 0.0327),计算机技能较少(p = 0.0003)。在老年患者和生活质量较低的患者中发现了前瞻性使用ePRO的障碍。考虑到年龄、教育程度和当前健康状况等适当条件,应提供参与机会,以鼓励患者参与意愿并确保调查结果的有效性。关注ePRO应用程序的易用性并使应用程序更以患者为导向且简单明了似乎是前进的方向。